Project

An open-label, mulit-center, phase II platform study evaluating the efficacy and safety of NIS793 and other new investigational drug com-binations with standard of care (SOC) anti-cancer therapy for the second line treatment of metastatic colorectal cancer (mCRC)

Ongoing - recruitment closed · 2022 until 2025

Weisshaupt Christian, Aeschbacher Anette, Frehner Jan